<!DOCTYPE html>
<html>

<head>
    <style type="text/css">
        p {
            opacity: 0;
        }

        /* title */
        .title-box-new {
            /* margin: 5vw 5vw 2vw 5vw; */
            position: relative;
            width: 100%;

        }

        .title-big h1 {
            font-size: 6vw !important;
            /* line-height:14vw; */

        }

        .title-big>.title-box-title {
            border-left-style: none !important;
            border-bottom-style: solid;
            border-color: rgb(255, 55, 68);
            border-bottom-width: 0.2vw;

        }

        .title-box-mask {
            position: absolute;

            height: 100%;

            background-color: rgb(255, 55, 68);
        }

        .title-box-mask-left {
            left: 0;
        }

        .title-box-mask-right {
            right: 0;
        }

        .title-box-title {
            /* width: 100%; */
            height: inherit;
            border-left-style: solid;
            border-color: rgb(255, 55, 68);
            border-left-width: 0.25rem;
            opacity: 0;
            display: flex;
            /* justify-content-design: center; */


        }

        .title-big h1 {
            flex-grow: 1;
            vertical-align: middle;
            text-align: center;
            margin: 0;
            font-size: 8rem;
            color: rgb(25, 46, 67);
        }

        .title-box-title>h1 {
            /* flex-grow: 1; */
            vertical-align: middle;
            /* text-align:center; */
            padding: 0 4rem;
            margin: 0;
            font-size: 8rem;
            color: rgb(25, 46, 67);
        }

        /* title end */
        /* reference */

        /* reference end */
        /* content-design start */
        /* arrow start */
        .arrow {
            opacity: 0;
        }

        .arrow_1 {
            display: flex;
            align-items: center;
            justify-content: center;
        }

        .arrow_1>img {
            width: 15vw;
        }

        .arrow_2 {
            display: flex;
            align-items: center;
            justify-content: center;
        }

        .arrow_2>img {
            width: 8vw;
        }

        /* arrow end */

        /* video */


        .video-1 {
            width: 30vw;
        }

        .video-box {
            width: 100% !important;
        }

        /* video end */

        /* content start */
        .content-text p {
            color: rgb(25, 46, 67);
        }

        h4 {
            font-family: "Myanmar Text" !important;
            padding: 4rem;
        }

        .content-1 p,
        .content-2 p,
        .content-3 p,
        .content-4 p,
        .content-5 p,
        .content-6 p,
        .content-7 p {
            /* font-size: 1.1vw; */
            color: rgb(25, 46, 67);
            text-align: justify;
            /* font-family: "Myanmar Text" !important; */
        }

        /* content-1-2 */

        .content-1-2 {
            display: flex;
            /* width: 80vw; */
            /* margin: 10vw 10vw 2vw 10vw; */
        }

        .content-1,
        .content-2 {
            width: 50%;
            height: 100%;
            display: flex;
            flex-direction: column;
            justify-content: center;
            align-items: center;
            flex-grow: 1;
        }

        .content-1 {
            padding: 0 2.5vw 0 0;
        }

        .content-2 {
            padding: 0 0 0 2.5vw;
        }

        /* content-3 */

        .content-3 {
            display: flex;
            flex-direction: column;
            align-items: center;
            justify-content: center;
            /* width: 60vw; */
            /* height: 43vw; */
            /* margin: 0vw 20vw; */
        }

        /* content-4 */

        .content-4 {
            display: flex;
            flex-direction: column;
            align-items: center;
            /* width: 60vw; */
            /* height: 50vw; */
            /* margin: 2vw 20vw; */
        }

        .content-5 {
            display: flex;
            flex-direction: column;
            align-items: center;
            /* width: 60vw; */
            /* height: 68vw; */
            /* margin: 2vw 20vw; */
        }

        .content-5-h4 {
            align-self: flex-start;
            color: rgb(25, 46, 67);
            text-align: justify;
            /* font-size: 1.5vw; */
        }

        .content-mask {


            flex-direction: column;
            position: absolute;
        }

        .content-mask-0 {

            width: 100%;
            height: 50%;
            background-color: rgb(25, 46, 67);

            left: 0;
            float: left;
        }

        .content-mask-1 {
            width: 100%;
            height: 50%;
            background-color: rgb(255, 55, 68);
            top: 11vw;
            position: absolute;
            right: 0;
            float: right;
        }

        .content-mask-2 {

            width: 100%;
            height: 50%;
            background-color: rgb(25, 46, 67);

            left: 0;
            float: left;
        }

        .content-mask-3 {
            width: 100%;
            height: 50%;
            background-color: rgb(255, 55, 68);
            top: 9vw;
            position: absolute;
            right: 0;
            float: right;
        }

        .content-6 {
            /* width: 80vw; */
            /* margin: 2vw 10vw; */
            height: 35vw;

        }

        .content-mask-6 {
            width: 100%;
            height: 22vw;
        }

        .content-6 p {
            /* font-size: 1.1vw; */
            text-align: justify;

        }

        .content-7 {
            /* width: 80vw; */
            height: 54vw;
            /* margin: 2vw 10vw; */
        }

        .content-mask-7 {
            width: 100%;
            height: 18vw;
        }

        .content-7 p {
            /* font-size: 1.1vw; */
            text-align: justify;

        }

        /* content end */

        /* table */

        /* table,
        table tr th,
        table tr td {
            border: 2px solid #000000;
            color: rgb(25, 46, 67);
            font-family: "Myanmar Text" !important;
            font-size: 1vw;
        }

        td {
            padding: 0.5em;
        }

        .tr-double {
            background-color: rgb(217, 217, 217);
        }

        table {
            width: 65vw;
            height: 40vw;
            min-height: 25px;

            text-align: center;
            border-collapse: collapse;
        }

        .my-vertical-align {
            display: flex;
            align-items: center;
            flex-wrap: wrap;
        } */

        /* table end */

        /* content-design end */
    </style>
    <!-- standard head -->
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <script type="text/javascript"
        src="https://2019.igem.org/wiki/index.php?title=Team:SYSU-Medicine/js/jquery&action=raw&ctype=text/javascript"></script>
    <link type="text/css" rel="stylesheet"
        href="https://2019.igem.org/wiki/index.php?title=Team:SYSU-Medicine/css/default&action=raw&ctype=text/css" />
    <script type="text/javascript"
        src="https://2019.igem.org/wiki/index.php?title=Team:SYSU-Medicine/js/home&action=raw&ctype=text/javascript"></script>
    <link rel="stylesheet"
        href="https://2019.igem.org/wiki/index.php?title=Team:SYSU-Medicine/css/bootstrap&action=raw&ctype=text/css">
    <script
        src="https://2019.igem.org/wiki/index.php?title=Team:SYSU-Medicine/js/bootstrap&action=raw&ctype=text/javascript"></script>
    <link type="text/css" rel="stylesheet"
        href="https://2019.igem.org/wiki/index.php?title=Team:SYSU-Medicine/css/style&action=raw&ctype=text/css" />
    <!-- standard head end -->
    <!-- <link type="text/css" rel="stylesheet"
        href="https://2019.igem.org/wiki/index.php?title=Team:SYSU-Medicine/css/safety&action=raw&ctype=text/css" />
    <script type="text/javascript"
        src="https://2019.igem.org/wiki/index.php?title=Team:SYSU-Medicine/js/safety&action=raw&ctype=text/javascript"></script> -->

    <!-- <link type="text/css" rel="stylesheet" href="safety.css"> -->
    <!-- <script src="safety.js"></script> -->
    <!-- <link type="text/css" rel="stylesheet" href="./navigation.css">
    <script src="./navigation.js"></script> -->


    <title>INSPIRATION</title>

</head>

<body>
    <!-- <div class="debug" style= "position:fixed;top:6rem">
        <a class="a">a</a>
    </div> -->
    	<div class="container">
		<div class="row">
			<div class="col-sm-12 column">
				<nav class="navigation" id="nav-top">
					<ul class="navigation-list nav-justified">
						<div class="navigation-blue navigation-div">
							<li class="navigation-item activate ">
								<a class="navigation-item-link "
									href="https://2019.igem.org/Team:SYSU-Medicine">Home</a>
								<ul class="navigation-dropdown-panel"></ul>
							</li>
							<li class="navigation-item dropdown">
								<a class="navigation-item-link "
									>Project</a>
								<ul class="navigation-dropdown-panel ">
									<li class="navigation-subitem">
										<a href="https://2019.igem.org/Team:SYSU-Medicine/Description">Description</a>
									</li>
									<li class="navigation-subitem">
										<a href="https://2019.igem.org/Team:SYSU-Medicine/Design">Design</a>
									</li>
									<li class="navigation-subitem">
										<a href="https://2019.igem.org/Team:SYSU-Medicine/Results">Results</a>
									</li>
									<li class="navigation-subitem">
										<a href="https://2019.igem.org/Team:SYSU-Medicine/Experiments">Experiments</a>
									</li>
									<li class="navigation-subitem">
										<a href="https://2019.igem.org/Team:SYSU-Medicine/Inspiration">Inspiration</a>
									</li>
								</ul>
							</li>
							<li class="navigation-item dropdown">
								<a class="navigation-item-link"
									>Model</a>
								<ul class="navigation-dropdown-panel">
									<li class="navigation-subitem">
										<a href="https://2019.igem.org/Team:SYSU-Medicine/Model">Overview</a>
									</li>
									<li class="navigation-subitem">
										<a href="https://2019.igem.org/Team:SYSU-Medicine/M1_Cultivation">M1 Cultivation
										</a>
									</li>
									<li class="navigation-subitem">
										<a href="https://2019.igem.org/Team:SYSU-Medicine/Injection_System">Injection
											System
										</a>
									</li>
									<li class="navigation-subitem">
										<a href="https://2019.igem.org/Team:SYSU-Medicine/TES">T. E. S.</a>
									</li>
									<li class="navigation-subitem">
										<a href="https://2019.igem.org/Team:SYSU-Medicine/Future">Future</a>
									</li>
								</ul>
							</li>
							<li class="navigation-item dropdown ">
								<a class="navigation-item-link"
									>Human Practices</a>
								<ul class="navigation-dropdown-panel ">
									<li class="navigation-subitem">
										<a href="https://2019.igem.org/Team:SYSU-Medicine/Human_Practices">Overview
										</a>
									</li>
									<li class="navigation-subitem">
										<a href="https://2019.igem.org/Team:SYSU-Medicine/Integrated_Practices">Integrated
											Practices
										</a>
									</li>
									<li class="navigation-subitem">
										<a href="https://2019.igem.org/Team:SYSU-Medicine/Public_Engagement">Education &
											Engagement
										</a>
									</li>
								</ul>
							</li>

						</div>
						<div class="navigation-red navigation-div">
							<li class="navigation-item dropdown ">
								<a class="navigation-item-link "
									>Parts</a>
								<ul class="navigation-dropdown-panel ">
									<li class="navigation-subitem">
										<a href="https://2019.igem.org/Team:SYSU-Medicine/Parts">Parts Overview</a>
									</li>
									<li class="navigation-subitem">
										<a href="https://2019.igem.org/Team:SYSU-Medicine/Parts#Basic_Part">Basic Parts</a>
									</li>
									<li class="navigation-subitem">
										<a href="https://2019.igem.org/Team:SYSU-Medicine/Parts#Composite_Part">Composite
											Parts
										</a>
									</li>
									<li class="navigation-subitem">
										<a href="https://2019.igem.org/Team:SYSU-Medicine/Parts#Part_Collection">Part
											Collection
										</a>
									</li>
								</ul>
							</li>

							<li class="navigation-item ">
								<a class="navigation-item-link"
									href="https://2019.igem.org/Team:SYSU-Medicine/Safety">Safety</a>
								<ul class="navigation-dropdown-panel"></ul>
							</li>
							<li class="navigation-item ">
								<a class="navigation-item-link"
									href="https://2019.igem.org/Team:SYSU-Medicine/Medal">Awards</a>
								<ul class="navigation-dropdown-panel">
									<li class="navigation-subitem">
										<a href="https://igem.org/2019_Judging_Form?team=SYSU-Medicine">Judging</a>
									</li>
								</ul>
							</li>
							<li class="navigation-item dropdown ">
								<a class="navigation-item-link "
									>Team</a>
								<ul class="navigation-dropdown-panel ">
									<li class="navigation-subitem">
										<a href="https://2019.igem.org/Team:SYSU-Medicine/Team">Team Members</a>
									</li>
									<li class="navigation-subitem">
										<a
											href="https://2019.igem.org/Team:SYSU-Medicine/Collaborations">Collaborations</a>
									</li>
									<li class="navigation-subitem">
										<a href="https://2019.igem.org/Team:SYSU-Medicine/Attributions">Attributions</a>
									</li>
								</ul>
							</li>
						</div>

					</ul>
				</nav>
			</div>
		</div>
	</div>

    <!-- <div class="piano-subpage piano-subpage-demo">
    <div id="content-design-0-key" class="piano-subpage-key piano-subpage-key-0"><div class="key-kernel key-kernel-0"></div></div>
    <div id="content-design-1-key" class="piano-subpage-key piano-subpage-key-1"><div class="key-kernel key-kernel-1"></div></div>
    <div id="content-design-2-key" class="piano-subpage-key piano-subpage-key-2"><div class="key-kernel key-kernel-2"></div></div>
    <div id="content-design-3-key" class="piano-subpage-key piano-subpage-key-3"><div class="key-kernel key-kernel-3"></div></div>
    <div id="content-design-4-key" class="piano-subpage-key piano-subpage-key-4"><div class="key-kernel key-kernel-4"></div></div>
    <div id="content-design-5-key" class="piano-subpage-key piano-subpage-key-5"><div class="key-kernel key-kernel-5"></div></div>
    </div> -->
    <!-- <div class="title-margin">
        <div class="row clearfix">
            <div class="col-xs-10">
                <div class="title-box">
                    <h1 class="title">
                        <span class="title-has-mask playing">Human Practices</span>
                        <span class="title-mask playing"></span>
                    </h1>
                </div>
            </div>
        </div>
    </div> -->
    <div class="clearfix" style="margin-bottom: 18em;"></div>
    <div class="container-fluid std-content">
        <div class="row">
            <div class="col-xs-6 col-xs-offset-3">
                <div class="title-box-new title-big">
                    <div class="title-box-mask"></div>
                    <div class="title-box-title">
                        <h1>INSPIRATION</h1>
                    </div>
                </div>
            </div>
        </div>
        <!-- <div class="clearfix" style="margin-bottom: 5em;"></div>
        <div class="row">
            <div class="col-xs-10 col-xs-offset-1">
                <div class="title-box-new title-0">
                    <div class="title-box-mask"></div>
                    <div class="title-box-title">
                        <h1>Inspiration</h1>
                    </div>
                </div>
            </div>
        </div> -->
        <div class="clearfix" style="margin-bottom: 5em;"></div>
        <div class="row">
            <div class="col-xs-8 col-xs-offset-2">

                <div class="content-design content-design-0">
                    <div class="content-1-2">
                        <div class="content-1">
                            <video class="video-box" autoplay="autoplay" muted="muted" loop="loop">
                                <source src="https://2019.igem.org/wiki/images/6/6f/T--SYSU-Medicine--design_1.mp4"
                                    type="video/mp4"></video>
                            <p>
                                With the increasing incidence and mortality of cancer, there are
                                many limitations of
                                the current
                                anti-tumor treatments. So the original idea of our project was to improve the cancer
                                therapies, we were
                                looking for a new treatment that combines the strengths of the current approaches.
                                Later, we found that
                                oncolytic virus therapy has recently been recognized as a promising new therapeutic
                                approach for cancer
                                treatment. It combines immune therapy, gene therapy and advantages of targeted drugs,
                                which can
                                selectively replicate in and kill cancer cells without harming the normal tissues. In
                                contrast to gene
                                therapy where a virus is used as a mere carrier for transgene delivery, oncolytic virus
                                therapy uses the
                                virus itself as an active drug reagent.
                            </p>
                        </div>
                        <div class="content-2">
                            <video class="video-box" autoplay="autoplay" muted="muted" loop="loop">
                                <source src="https://2019.igem.org/wiki/images/8/84/T--SYSU-Medicine--design_2.mp4"
                                    type="video/mp4"></video>
                            <p>
                                Although the advantages of oncolytic virus are obvious, the ability of the virus to
                                spread in tumor also limit the efficacy of oncolytic virus. To expand the anti-tumor
                                effect of M1, we further studied the mechanism of M1, and then we have hypothesized that
                                if M1 is combined with a chemotherapy drug that acts on DNA double-stranded, the
                                combined treatment could induce better antitumor effect efficiently. Therefore, CB1954,
                                Actinomycin D, Etoposide and other drugs were selected, and it was found that CB1954
                                have great effect combined with M1. Previous studies have confirmed that compared with
                                the HSV1-tk-GCV system, the advantages of the NTR/CB1954 system are as follows: i)
                                Independence from the cell cycle; ii) ability to target both dividing and
                                growth-arrested cancer cells; and iii) induction of a potent bystander effect on the
                                cell cycle[1]. Furthermore, it even has a powerful effect on enhancing M1's infection to
                                tumor cells.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
        <div class="clearfix" style="margin-bottom: 5em;"></div>


        <div class="row">
            <div class="col-xs-12">
                <div class="arrow arrow_1">
                    <img src="https://2019.igem.org/wiki/images/6/6b/T--SYSU-Medicine--arrow_1.svg">
                </div>
            </div>
        </div>
        <div class="row">
            <div class="col-xs-8 col-xs-offset-2">
                <div class="row my-vertical-align">
                    <!-- <div class="col-xs-2">
                        <div class="content-3">
                            <p>&nbsp&nbsp&nbsp&nbspHowever, Actinomycin D has many side effects, such as
                                myelosuppression,
                                gastrointestinal
                                reactions, liver
                                function impairment etc.</p>
                        </div>
                    </div> -->
                    <div class="col-xs-8 col-xs-offset-2"><video class="video-box" autoplay="autoplay" muted="muted"
                            loop="loop">
                            <source src="https://2019.igem.org/wiki/images/8/87/T--SYSU-Medicine--design_3.mp4"
                                type="video/mp4"></video></div>
                    <!-- <div class="col-xs-2">
                        <div class="content-3">
                            <p>
                                &nbsp&nbsp&nbsp&nbspAccordingly, it is of vital importance to improve its targeting
                                ability, which is
                                exactly one of the most significant advantages of M1.
                            </p>
                        </div>

                    </div> -->
                    <div class="col-xs-12">
                        <div class="content-3">
                            <p>
                                The crucial factor to achieve the efficacy of the NTR/CB1954 system is having the good
                                targeting of vector, which is exactly one of the most significant advantages of M1.
                                Previous studies have reported that the prodrug of CB1954 can be activated by
                                nitroreductase. Therefore, we designed this system to combine M1 virus with CB1954 for
                                cancer treatment. We engineered M1 armed with nitroreductase, and after nitroreductase
                                was delivered to the cancer cell by M1 and expressed, the enzyme can activate
                                subsequently administered prodrugs of CB1954 to potent drugs.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
        <div class="clearfix" style="margin-bottom: 5em;"></div>
        <div class="row">
            <div class="col-xs-12">
                <div class="arrow arrow_2">
                    <img src="https://2019.igem.org/wiki/images/5/55/T--SYSU-Medicine--arrow_2.svg">
                </div>
            </div>
        </div>
        <div class="clearfix" style="margin-bottom: 5em;"></div>
        <div class="row">
            <div class="col-xs-8 col-xs-offset-2">
                <div class="row my-vertical-align">
                    <!-- <div class="col-xs-2">
                        <div class="content-4">
                            <p>&nbsp&nbsp&nbsp&nbspPrevious studies have reported that the prodrug of actinomycin D can
                                be
                                activated by
                                nitroreductase.
                                Therefore, we designed this system to combine M1 virus with actinomycin D for cancer
                                treatment.
                                We
                                engineered M1 armed with nitroreductase, and after nitroreductase was delivered to the
                                cancer
                                cell by M1 and
                                expressed, the enzyme can activate subsequently administered prodrugs of actinomycin D
                                to potent
                                drugs.</p>
                        </div>
                    </div> -->
                    <div class="col-xs-6 col-xs-offset-3"><video class="video-box" autoplay="autoplay" muted="muted"
                            loop="loop">
                            <source src="https://2019.igem.org/wiki/images/c/c9/T--SYSU-Medicine--design_4.mp4"
                                type="video/mp4"></video></div>
                    <!-- <div class="col-xs-2">
                        <div class="content-4">
                            <p>
                                &nbsp&nbsp&nbsp&nbspFurther, actinomycin D can promote the replication of M1 virus,
                                which made up a constant
                                reinforcing system.

                                In addition, in order to ensure the controllability and safety of the system, we used
                                engineered
                                riboswitches to control gene expression of M1 armed with nitroreductase.
                            </p>
                        </div>

                    </div> -->
                    <div class="col-xs-12">
                        <div class="content-4">
                            <p>
                                In our prodrug system, if the replication of M1 virus was out of control, the prodrug of
                                CB1954 would be activated, the toxicity of CB1954 could cause some side effects.
                                Therefore, in order to ensure the controllability and safety of the system, we used
                                engineered riboswitches to control gene expression of M1 armed with nitroreductase.
                            </p>
                        </div>

                    </div>
                </div>
            </div>

        </div>
    </div>
    <div class="container-fluid std-content">
        <div class="clearfix" style="margin-bottom: 5em;"></div>
        <div class="row">
            <div class="col-xs-10 col-xs-offset-1">
                <div class="title-box-new title-4">
                    <div class="title-box-mask"></div>
                    <div class="title-box-title">
                        <h1>Initial Ideas</h1>
                    </div>
                </div>
            </div>

        </div>
        <div class="clearfix" style="margin-bottom: 5em;"></div>
        <div class="row">
            <div class="col-xs-8 col-xs-offset-2">
                <div class="content-5">




                    <h4 class="content-5-h4">
                        Prior to our initial survey, we had many different ideas for potential projects:
                    </h4>

                    <table class="table table-bordered table-striped">
                        <tr>
                            <td></td>
                            <td><b>Purpose</b></td>
                            <td><b>Benefits</b></td>
                            <td><b>Limitations</b></td>
                        </tr>
                        <tr>
                            <td><b>Directed evolution</b></td>
                            <td>We constructed the M1 with low fidelity RNA polymerase to increase the probability of
                                mutation caused by adaptation, to expand the anti-cancer spectrum of M1 virus by
                                continuous
                                passage.</td>
                            <td>Overcome the limitations of the complex regulation mechanism of virus-host interaction.
                            </td>
                            <td>Mutations are unpredictable;
                                Uncertainty.
                            </td>
                        </tr>
                        <tr>
                            <td><b>Engineer M1 with ligands</b></td>
                            <td>We inserted ligands of receptors that are highly expressed in some tumors, such as EGF,
                                HER2, etc., which aims to enhance the affinity between M1 and insensitive tumor cells.
                            </td>
                            <td>Enhance the affinity between M1 and insensitive tumor cells. </td>
                            <td>The insertion of ligands into the M1 genome may affect the replication of M1.
                            </td>
                        </tr>
                        <tr>
                            <td><b>M1-directed enzyme system</b></td>
                            <td>We used M1 as a viral vector to deliver the gene of enzyme, after the enzyme is
                                expressed,
                                the ability to specifically activate subsequently administered and otherwise inert
                                prodrugs
                                to potent drugs, which allows for a specific therapy with limited systemic side effects.
                            </td>
                            <td>Increase the lethality to tumor cells. It can significantly increase the targeting of
                                chemotherapy drugs and reduce its side effects.
                            </td>
                            <td>The prodrug and M1 virus need to be administered separately.</td>
                        </tr>
                        <tr>
                            <td><b>3D culture</b></td>
                            <td>Better simulation of the vivo environment, to improve the affinity of M1 to insensitive
                                cells
                                and enhance its anti- tumor effect.</td>
                            <td>Reduce the affinity of normal cells and improve the safety of M1; Enhance the oncolysis
                                of
                                M1.</td>
                            <td>The lack of a standard approach.</td>
                        </tr>
                        <tr>
                            <td><b>M1 armed with Cytokines</b></td>
                            <td>Encode cytokine such as IL-2、 IL-4 in the M1 vector to induce T cell responses of
                                sufficient
                                magnitude</td>
                            <td>Enhance adaptive immune responses.</td>
                            <td>Causes premature elimination of M1; It is limited by the rate of infection.</td>
                        </tr>
                        <tr>
                            <td><b>Combination with PD-1 or PD-L1 antibody</b></td>
                            <td>Using OVs to heat up ‘cold’ tumors for immune checkpoint blockade, such as PD L1 or PD1,
                                and
                                then increase the antitumor effect.</td>
                            <td>In a number of other preclinical studies, ICIs have been shown to increase the efficacy
                                of
                                OV therapy involving a variety of viral platforms.</td>
                            <td>Hard to regulate the concentration of drug administration;
                                This brings substantially increased toxicity to patients.
                            </td>
                        </tr>

                    </table>
                    <!-- <h4 class="content-5-h4">However, after we did the pre-experiments of two projects, the results was not
                    as
                    expect. So we decided to try another project to expand the anti-cancer spectrum of M1 virus. We
                    designed to
                    engineer M1 to specifically encode and express enzymes that can convert prodrugs into active
                    therapeutic
                    metabolites and enhance bystander effects of chemicals. Finally, we proved that this project was
                    feasible.
                    </h2> -->

                </div>
            </div>

        </div>
        <div class="clearfix" style="margin-bottom: 5em;"></div>
        <div class="row">
            <div class="col-xs-10 col-xs-offset-1">
                <div class="title-box-new title-4">
                    <div class="title-box-mask"></div>
                    <div class="title-box-title">
                        <h1>Final Project Decision</h1>
                    </div>
                </div>
            </div>

        </div>
        <div class="clearfix" style="margin-bottom: 5em;"></div>
        <div class="row">
            <div class="col-xs-8 col-xs-offset-2">
                <div class="content-5">
                    <p>Though interviewed the professor Yan, and taking into account the innovation and
                        feasibility of each project, we subsequently decide to try the following three projects: 1)
                        Directed
                        evolution; 2) Engineer M1 with ligands; 3) M1-directed enzyme system. However, after we did the
                        pre-experiments of the first two projects, the results can not satisfy our expectation. Thus we
                        decided
                        to the third project to expand the anti-cancer spectrum of M1 virus. We designed to engineer M1
                        to
                        specifically encode and express enzymes that can convert prodrugs into active therapeutic
                        metabolites
                        and enhance bystander effects of chemicals. As the result have shown, we proved that this
                        project
                        was
                        feasible.

                    </p>
                </div>

            </div>
        </div>
    </div>

    <!-- <div class="clearfix" style="margin-bottom: 5em;"></div>
    <div class="row">
        <div class="col-xs-10 col-xs-offset-1">
            <div class="title-box-new title-4">
                <div class="title-box-mask"></div>
                <div class="title-box-title">
                    <h1>Directed evolution</h1>
                </div>
            </div>
        </div>

    </div>
    <div class="clearfix" style="margin-bottom: 5em;"></div>
    <div class="row">
        <div class="col-xs-8 col-xs-offset-2">
            <div class="content-6">
                <div class="content-6-0">
                    <div class="content-text">
                        <p>
                            Since the interaction between virus and host is extremely complex and diverse, and a large
                            number of
                            molecular interaction regulatory networks have not been clarified, the ability to use these
                            molecular
                            mechanisms for virus modification is limited.
                            The biggest difference between oncolytic virus and replicator-deficient virus vectors and
                            other
                            anticancer drugs is that OVs can replicate and mutate, and thus has the potential to evolve
                            under
                            the
                            pressure of natural selection, and the direction of evolution can be directed in a
                            controlled
                            laboratory
                            environment.</p>
                        <p>
                            Therefore, we considered to construct the M1 with low fidelity RNA polymerase to increase
                            the
                            probability of mutation caused by adaptation. In addition, we inserted ligands of receptors
                            that are
                            highly expressed in some tumors, which aims to enhance the affinity between M1 and
                            insensitive tumor
                            cells.</p>
                    </div>
                </div>
                <div class="content-6-1">
                    <div class="content-mask content-mask-6">
                        <div class="content-mask-0"></div>
                        <div class="content-mask-1"></div>
                    </div>
                    <div class="content-text">

                        <p><b>
                                Pros:</b></p>
                        <p>
                            1. Increase the fitness and oncoselectivity of previously engineered oncolytic virus</p>
                        <p>
                            2. Overcome some of the limitations imposed by the complexity of virus–host interactions.
                        </p>
                        <p>
                            3. Combine all the mutation site, it could obtain the high efficiency of new broad-spectrum
                            oncolytic
                            virus M1.</p>
                        <p><b>Cons:</b>
                        </p>
                        <p>
                            1. The mutation is uncertain. It is hard to predict whether M1 will evolve into a new virus
                            which
                            has a
                            boarder anti-tumor spectrum and stronger anti-tumor effect.

                        </p>
                    </div>
                </div>

            </div>
        </div>

    </div>
    <div class="clearfix" style="margin-bottom: 5em;"></div>
    <div class="row">
        <div class="col-xs-10 col-xs-offset-1">
            <div class="title-box-new title-4">
                <div class="title-box-mask"></div>
                <div class="title-box-title">
                    <h1>3D culture</h1>
                </div>
            </div>
        </div>

    </div>
    <div class="clearfix" style="margin-bottom: 5em;"></div>
    <div class="row">
        <div class="col-xs-8 col-xs-offset-2">
            <div class="content-7">
                <div class="content-7-0">
                    <div class="content-text">
                        <p>
                            Three-dimensional cell culture model can better simulate the natural developing environment
                            in vivo.
                            3D
                            cell culture can establish physiological cell-cell and cell-extracellular matrix interaction
                            and
                            restore
                            the metabolic pattern of cells in tissues, so as to be closer to the characteristics of
                            natural
                            tissues.
                            Its physiological correlation is significantly stronger than traditional two-dimensional
                            cell
                            culture.
                            This is important in cancer research.
                            Recent studies have reported that a variety of oncolytic viruses have developed a new
                            generation of
                            oncolytic viruses using three-dimensional culture models, such as adenovirus for the
                            treatment of
                            colon
                            cancer, reovirus for the treatment of glioblastoma, herpes simplex virus for the treatment
                            of
                            melanoma
                            and breast cancer, etc. </p>
                        <p>
                            We considered to use 3D culture to improve the fitness of M1 to insensitive cells, in order
                            to
                            expand
                            the anti-tumor spectrum of M1 and enhance its anti- tumor effect. </p>
                    </div>
                </div>
                <div class="content-7-1">
                    <div class="content-mask content-mask-7">
                        <div class="content-mask-2"></div>
                        <div class="content-mask-3"></div>
                    </div>
                    <div class="content-text">

                        <p><b>Pros:</b>
                        </p>
                        <p>
                            1. It could not only reduce the fitness of normal cells and improve the safety of M1, but
                            also
                            enhance
                            the oncolysis of M1 and develop the next generation of effective oncolytic virus M1.</p>
                        <p>
                            2. The data that we obtained from 3D culture are more clinically relevant. </p>
                        <p><b>Cons:</b>
                        </p>
                        <p>
                            One major problem in the field is the lack of a standard approach in 3D cultures, whereas 2D
                            cell
                            culture practice is standard and roughly comparable. </p>
                        <p>

                    </div>
                </div>

            </div>
        </div>

    </div>
    </div>
    <div class="clearfix" style="margin-bottom: 5em;"></div>
    <div class="row">
        <div class="col-xs-10 col-xs-offset-1">
            <div class="title-box-new title-5">
                <div class="title-box-mask"></div>
                <div class="title-box-title">
                    <h1 class="reference-title">REFERENCE</h1>
                </div>
            </div>
        </div>
    </div>
    <div class="clearfix" style="margin-bottom: 5em;"></div>
    <div class="row">
        <div class="col-xs-8 col-xs-offset-2">
            <div class="reference-content-design">
                <p>[1] Yuan Lin al. Identification and characterization of alphavirus M1 as a selective oncolytic
                    virus
                    targeting ZAP-defective human cancers. PNAS 2014:E4504-E4512
                </p>
            </div>
        </div>
    </div>
    </div> -->




    <div class="space" style="height: 30vw;"></div>
</body>
<script type="text/javascript">
    // title
    $(document).ready(function () {
        speed = 250;
        $(".title-box-new").each(function (titlebox_i, title_box) {
            var last = $(title_box).offset().top - $(window).scrollTop();
            var viewheight = window.innerHeight / 5 * 4;
            if (last < viewheight) {
                if ($(title_box).hasClass("played")) { } else {
                    $(title_box).addClass("played");

                    $(title_box).children(".title-box-mask").addClass("title-box-mask-left");
                    $(title_box).children(".title-box-mask").animate({ width: $(title_box).find("h1").outerWidth() }, speed, "swing", function () {
                        $(title_box).children(".title-box-mask").removeClass("title-box-mask-left");
                        // console.log($(title_box).width());
                        // console.log($(title_box).find("h1").width());
                        console.log(parseInt($(title_box).find(".title-box-title").css("border-left-width")));
                        var cache = $(title_box).width() - $(title_box).find("h1").outerWidth();
                        $(title_box).children(".title-box-mask").css("right", cache);
                        // $(title_box).children(".title-box-mask").addClass("title-box-mask-right");
                        $(title_box).children(".title-box-title").animate({ opacity: "100" }, speed / 2);
                    });
                    $(title_box).children(".title-box-mask").animate({ width: "0" }, speed, "swing");
                }


            }
        });
    })
    $(document).scroll(function () {
        speed = 250;
        $(".title-box-new").each(function (titlebox_i, title_box) {
            var last = $(title_box).offset().top - $(window).scrollTop();
            var viewheight = window.innerHeight / 5 * 4;
            if (last < viewheight) {
                if ($(title_box).hasClass("played")) { } else {
                    $(title_box).addClass("played");

                    $(title_box).children(".title-box-mask").addClass("title-box-mask-left");
                    $(title_box).children(".title-box-mask").animate({ width: $(title_box).find("h1").outerWidth() }, speed, "swing", function () {
                        $(title_box).children(".title-box-mask").removeClass("title-box-mask-left");
                        // console.log($(title_box).width());
                        // console.log($(title_box).find("h1").width());
                        console.log(parseInt($(title_box).find(".title-box-title").css("border-left-width")));
                        var cache = $(title_box).width() - $(title_box).find("h1").outerWidth();
                        $(title_box).children(".title-box-mask").css("right", cache);
                        // $(title_box).children(".title-box-mask").addClass("title-box-mask-right");
                        $(title_box).children(".title-box-title").animate({ opacity: "100" }, speed / 2);
                    });
                    $(title_box).children(".title-box-mask").animate({ width: "0" }, speed, "swing");
                }


            }
        });
    })

    // title end
    //content
    //mask
    $(document).scroll(function () {
        speed = 700
        $(".content-mask").each(function (titlebox_i, title_box) {
            var last = $(title_box).offset().top - $(window).scrollTop();
            var viewheight = window.innerHeight / 5 * 4;
            if (last < viewheight) {
                if ($(title_box).hasClass("played")) { } else {
                    $(title_box).addClass("played");
                    $(title_box).children().each(function (mask_i, mask) {
                        $(mask).animate({ width: "0" }, speed);
                    });
                    // $(title_box).children(".title-box-mask").addClass("title-box-mask-left");
                    // $(title_box).children(".title-box-mask").animate({ width: $(title_box).width() }, speed,"swing", function () {
                    //     $(title_box).children(".title-box-mask").removeClass("title-box-mask-left");
                    //     $(title_box).children(".title-box-mask").addClass("title-box-mask-right");
                    //     $(title_box).children(".title-box-title").animate({ opacity: "100" }, speed / 2);
                    // });
                    // $(title_box).children(".title-box-mask").animate({ width: "0" }, speed,"swing");
                }


            }
        });
    });
    //p
    $(document).scroll(function () {
        speed = 700
        $("p").each(function (titlebox_i, title_box) {
            var last = $(title_box).offset().top - $(window).scrollTop();
            var viewheight = window.innerHeight / 5 * 4;
            if (last < viewheight) {
                if ($(title_box).hasClass("played")) { } else {
                    $(title_box).addClass("played");
                    $(title_box).animate({ opacity: "100" }, 5000);

                }

            }
        });
    })
    //arrow
    $(document).scroll(function () {
        speed = 700
        $(".arrow").each(function (titlebox_i, title_box) {
            var last = $(title_box).offset().top - $(window).scrollTop();
            var viewheight = window.innerHeight / 5 * 4;
            if (last < viewheight) {
                if ($(title_box).hasClass("played")) { } else {
                    $(title_box).addClass("played");
                    $(title_box).animate({ opacity: "100" }, 5000);

                }

            }
        });
    })
//content end
</script>
<footer>
        <div style="background-color: rgb(25, 46, 67);" class="container-fluid std-content">
            <div class="row">
                <div class="col-xs-10 col-xs-offset-1">
                    <div class="row"  style="display: flex;align-items: center;">
                        <div  class="col-xs-6">
                            <div  style="display: flex;align-items: center;" class="row">
                                <div class="col-xs-8">
                                    <img style="width: 100%;"
                                        src="https://2019.igem.org/wiki/images/1/13/T--SYSU-Medicine--footer_logo.png">
                                </div>
                                <div class="col-xs-4">
                                    <img style="height:8em;" class="img-circle"
                                        src="https://2019.igem.org/wiki/images/f/fe/T--SYSU-Medicine--five_logo.png">
                                </div>
                            </div>
                        </div>
                        <div  class="col-xs-6">
                            <br/>
                            <p style="color: #fff;">Address: No.74 Zhongshan Rd.2, Guangzhou, P.R. China</p>
                            <p style="color: #fff;">ZipCode: 510080</p>
    
                            <p style="color: #fff;">E-mail: sysumedicine2019@163.com</p>
                        </div>
                    </div>
                </div>
            </div>
    
        </div>
    </footer>
</html>